When Patient Engagement and Research Ethics Collide: Lessons from a Dementia Forum

Journal of Alzheimer's Disease

Volumn 59, Issue 1, 2017, Pages 1-10

  Robillard, Julie M ^a   Feng, Tanya L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer's disease; dementia; ethics; informed consent; public policy; research ethics

Indexed keywords

ALZHEIMER DISEASE; BRITISH COLUMBIA; CLINICAL RESEARCH; DEMENTIA; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PUBLIC POLICY; RESEARCH ETHICS; REVIEW; RISK ASSESSMENT; ETHICS; FEMALE; INFORMATION DISSEMINATION; MALE; MEDICAL RESEARCH; PATIENT PARTICIPATION; PSYCHOLOGY;

BIOMEDICAL RESEARCH; DEMENTIA; ETHICS, RESEARCH; FEMALE; HUMANS; INFORMATION DISSEMINATION; INFORMED CONSENT; MALE; PATIENT PARTICIPATION;

EID: 85022179447     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-161285     Document Type: Review

References (59)

1. Emanuel EJ (2011) The Oxford Textbook of Clinical Research Ethics, Oxford University Press, USA.
2. Institute of Medicine (2001) Crossing the Quality Chasm: A New Health System for the 21st Century, National Academy Press, Washington, D. C.
3. Canadian Institutes of Health Research (2014) Strategy for patient-oriented research-patient engagement framework, http://www. cihr-irsc. gc. ca/e/48413. html.
4. Cotrell V, Schulz R (1993) The perspective of the patient with Alzheimer's disease:Aneglected dimension of dementia research. Gerontologist 33, 205-211.
5. Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jönsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu C, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg H (2016) Defeating Alzheimer's disease and other dementias: A priority for European science and society. Lancet Neurol 15, 455-532.
6. Neary D, Snowden J, Mann D (2005) Frontotemporal dementia. Lancet Neurol 4, 771-780.
7. Alzheimer's Disease International (2015) World Alzheimer report 2015: The global impact of dementia.
8. Cummings JL, MorstorfT, ZhongK(2014) Alzheimer's disease drug-development pipeline: Few candidates, frequent failures. Alzheimers Res Ther 6, 37.
9. Caron-Flinterman JF, Broerse JEW, Bunders JFG (2005) The experiential knowledge of patients: A new resource for biomedical research Soc. Sci Med 60, 2575-2584.
10. Hubbard G, Downs MG, Tester S (2003) Including older people with dementia in research: Challenges and strategies. Aging Ment Health 7, 351-362.
11. Bowen S, Martens P (2005) Demystifying knowledge translation: Learning from the community. J Health Serv Res Policy 10, 203-211.
12. WilkinsonH(2001) ThePerspectives ofPeople with Dementia: Research Methods and Motivations, Jessica Kingsley Publishers.
13. Hirschman KB, Xie SX, Feudtner C, Karlawish JHT (2004) How does an Alzheimer's disease patient's role in medical decision making change over time J Geriatr Psychiatry Neurol 17, 55-60.
14. Berghmans RLP, Meulen RHJT (1995) Ethical issues in research with dementia patients. Int J Geriatr Psychiatry 10, 647-651.
15. Albert SM, Sano M, Marder K, Jacobs DM, Brandt J, Albert M, Stern Y (1997) Participation in clinical trials and longterm outcomes in Alzheimer's disease. Neurology 49, 38-43.
16. Lidz CW, Albert K, Appelbaum P, Dunn LB, Overton E, Pivovarova E (2015) Why is therapeutic misconception so prevalent Camb Q Healthc Ethics 24, 231-241.
17. Karlawish JHT, Casarett DJ, James BD (2002) Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial. J Am Geriatr Soc 50, 2019-2024.
18. Grill JD, Karlawish J (2010) Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther 2, 34.
19. Jefferson AL, Lambe S, Chaisson C, Palmisano J, Horvath KJ, Karlawish J (2011) Clinical research participation among aging adults enrolled in an Alzheimer's disease center research registry. J Alzheimers Dis 23, 443-452.
20. Hewison J, HainesA(2006) Overcoming barriers to recruitment in health research. BMJ 333, 300-302.
21. Grill JD, Galvin JE (2014) Facilitating Alzheimer's disease researcher recruitment. Alzheimer Dis Assoc Disord 28, 1-8.
22. Kraft SA, Cho MK, Constantine M, Lee SS-J, Kelley M, Korngiebel D, James C, Kuwana E, Meyer A, Porter K, Diekema D, Capron AM, Alicic R, Wilfond BS, Magnus D (2016) A comparison of institutional review boardprofessionals' and patients' views on consent for research on medical practices. Clin Trials 13, 555-565.
23. Armstrong V, Barnett J, Cooper H, Monkman M, MOran-Ellis J, Shepherd R (2006) Public perspectives on the governance of biomedical research: A qualitative study in a deliberative context. Wellcome Trust, London, https://wellcomelibrary. org/item/b16625948.
24. Grady C (2015) Enduring and emerging challenges of informed consent. N Engl J Med 372, 855-862.
25. World Medical Association (2013) World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310, 2191-2194.
26. Davis AM, Hull SC, Grady C, Wilfond BS, Henderson GE (2002) The invisible hand in clinical research: The study coordinator's critical role in human subjects protection. J Law Med Ethics 30, 411-419.
27. Kass NE, Chaisson L, Taylor HA, Lohse J (2011) Length and complexity of US and international HIV consent forms from federal HIV network trials. J Gen Intern Med 26, 1324-1328.
28. Mittal D, Palmer BW, Dunn LB, Landes R, Ghormley C, Beck C, Golshan S, Blevins D, Jeste DV (2007) Comparison of two enhanced consent procedures for patients with mild Alzheimer disease or mild cognitive impairment. Am J Geriatr Psychiatry 15, 163-167.
29. Sugarman J, McCrory DC, Hubal RC (1998) Getting meaningful informed consent from older adults: A structured literature review of empirical research. J Am Geriatr Soc 46, 517-524.
30. Thomas SJ, Grossberg GT (2009) Memantine: A review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. Clin Interv Aging 4, 367-377.
31. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT, Group DS (1998) A 24-week, double-blind, placebocontrolled trial of donepezil in patients with Alzheimer's disease. Neurology 50, 136-145.
32. Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (2016) The antibody aducanumab reduces A- plaques in Alzheimer's disease. Nature 537, 50-56.
33. Farlow M, Arnold SE, Dyck CH, van, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER (2012) Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimers Dement 8, 261-271.
34. Oremus M, Wolfson C, Vandal AC, Bergman H, Xie Q (2007) Caregiver acceptance of adverse effects and use of cholinesterase inhibitors in Alzheimer's disease. Can J Aging 26, 205-212.
35. Ayalon L (2009) Willingness to participate in Alzheimer disease research and attitudes towards proxy-informed consent: Results from the health and retirement study. Am J Geriatr Psychiatry 17, 65-74.
36. Hauber AB, Johnson FR, Fillit H, Mohamed AF, Leibman C, Arrighi HM, Grundman M, Townsend RJ (2009) Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease: Alzheimer Dis. Assoc Disord 23, 23-32.
37. Dressler LG, Smolek S, Ponsaran R, Markey JM, Starks H, Gerson N, Lewis S, Press N, Juengst E, Wiesner GL, Consortium GRRIP (2012) IRB perspectives on the return of individual results from genomic research. Genet Med 14, 215-222.
38. Lévesque E, Joly Y, Simard J (2011) Return of research results: General principles and international perspectives. J Law Med Ethics 39, 583-592.
39. Illes J, Kirschen MP, Edwards E, Stanford LR, Bandettini P, Cho MK, Ford PJ, Glover GH, Kulynych J, Macklin R, Michael DB, Wolf SM (2006) Incidental findings in brain imaging research. Science 311, 783-784.
40. Meltzer LA (2006) Undesirable implications of disclosing individual genetic results to research participants. Am J Bioeth 6, 28-30; author reply W10-12.
41. Affleck P (2009) Is it ethical to deny genetic research participants individualised results J Med Ethics 35, 209-213.
42. Clayton E, Ross L (2006) Implications of disclosing individual results of clinical research. JAMA 295, 37-38.
43. Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA (2009) Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 361, 245-254.
44. Christensen KD, Roberts JS, Uhlmann WR, Green RC (2011) Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genet Med 13, 409-414.
45. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC (2008) Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord 22, 94-97.
46. Wallace SE, Kent A (2011) Population biobanks and returning individual research results: Mission impossible or new directions Hum Genet 130, 393-401.
47. Pulley JM, Brace MM, Bernard GR, Masys DR (2008) Attitudes and perceptions of patients towards methods of establishing a DNA biobank. Cell Tissue Bank 9, 55-65.
48. Pullman D, Buehler SK, Felt L, Gallagher K, House J, Keough TM, McDonald L, Power A, Ryan A (2009) Sorry, you can't have that information: Data holder confusion regarding privacy requirements for personal health information and the potential chilling effect on health research. Healthc Policy 4, 61-76.
49. LauPW, Illes J (2009) The gray zones of privatized imaging. Am J Bioeth 9, 21-22.
50. Lau CK, Schumacher HHA, Irwin MS (2010) Patients' perception of medical photography. J Plast Reconstr Aesthet Surg 63, e507-e511.
51. Malin B (2006) Re-identification of familial database records. AMIA Annu Symp Proc, 524-528.
52. Malin B, Loukides G, Benitez K, Clayton EW (2011) Identifiability in biobanks: Models, measures, and mitigation strategies. Hum Genet 130, 383.
53. McGuire AL, Gibbs RA (2006) No longer de-identified. Science 312, 370-371.
54. Meystre SM, Friedlin FJ, South BR, Shen S, Samore MH (2010) Automatic de-identification of textual documents in the electronic health record: A review of recent research. BMC Med Res Methodol 10, 70.
55. Trinidad SB, Fullerton SM, Bares JM, JarvikGP, Larson EB, Burke W (2010) Genomic research and wide data sharing: Views of prospective participants. Genet Med 12, 486-495.
56. Willison DJ, Steeves V, Charles C, Schwartz L, Ranford J, Agarwal G, Cheng J, Thabane L (2009) Consent for use ofpersonal information for health research: Do people with potentially stigmatizing health conditions and the general public differ in their opinions BMC Med Ethics 10, 10.
57. Tenopir C, Allard S, Douglass K, Aydinoglu AU, Wu L, Read E, ManoffM, FrameM(2011) Data sharing by scientists: Practices and perceptions. PLoS One 6, e21101.
58. Rathi V, Dzara K, Gross CP, Hrynaszkiewicz I, Joffe S, Krumholz HM, Strait KM, Ross JS (2012) Sharing of clinical trial data among trialists: A cross sectional survey. BMJ 345, e7570.
59. Taichman DB, Backus J, Baethge C, Bauchner H, de Leeuw PW, Drazen JM, Fletcher J, Frizelle FA, Groves T, Haileamlak A, James A, Laine C, Peiperl L, Pinborg A, Sahni P, Wu S (2016) Sharing clinical trial data-a proposal from the International Committee of Medical Journal Editors. N Engl J Med 374, 384-386.